![Anke Post](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Anke Post
Chief Tech/Sci/R&D Officer at
GENEURO SA
Net worth: 99 260 $ as of 2026-06-29
Profile
Anke Post is currently Chief Medical Officer at GeNeuro SA (Switzerland) since 2024.
Formerly, Chief Medical Officer at AC Immune SA from 2024 to 2025.
Education includes doctorates from Ludwig-Maximilians-Universität München and the University of Münster.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
AC IMMUNE SA 0.04% | 2026-02-28 | 41,706 ( 0.04% ) | 99 260 $ | 2026-06-29 |
Anke Post active positions
| Companies | Position | Start |
|---|---|---|
| GENEURO SA | Chief Tech/Sci/R&D Officer | 2024-01-04 |
Former positions of Anke Post
| Companies | Position | End |
|---|---|---|
| AC IMMUNE SA | Chief Tech/Sci/R&D Officer | 2025-05-31 |
Training of Anke Post
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
7
1st degree connections
4
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
AC Immune SA
 AC Immune SA Pharmaceuticals: MajorHealth Technology Manufactures precision medicines for neurodegenerative diseases | Health Technology |
University of Münster
 University of Münster Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ludwig-Maximilians-Universität München
 Ludwig-Maximilians-Universität München Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
GeNeuro SA (Switzerland)
 GeNeuro SA (Switzerland) BiotechnologyHealth Technology Engages in the research and development of pharmaceutical products to treat neurological diseases | Health Technology |
- Stock Market
- Insiders
- Anke Post
